Lupin LimitedNSE: LUPIN

Press Release Jul 16 2025

· Issued by Lupin Limited

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated July 16, 2025, titled "Lupin Launches Loteprednol Etabonate Ophthalmic Suspension, 0.5% in the United States".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases